Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Interest Expenses (2016 - 2018)

Lisata Therapeutics (LSTA) has disclosed Interest Expenses for 9 consecutive years, with $1666.0 as the latest value for Q2 2018.

  • For the quarter ending Q2 2018, Interest Expenses fell 99.19% year-over-year to $1666.0, compared with a TTM value of $1666.0 through Jun 2023, changed N/A, and an annual FY2018 reading of $5000.0, down 98.68% over the prior year.
  • Interest Expenses was $1666.0 for Q2 2018 at Lisata Therapeutics, down from $3000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $926800.0 in Q1 2016 and bottomed at $1666.0 in Q2 2018.
  • Average Interest Expenses over 5 years is $278111.7, with a median of $193980.5 recorded in 2014.
  • The sharpest move saw Interest Expenses surged 485.16% in 2015, then plummeted 99.19% in 2018.
  • Year by year, Interest Expenses stood at $372158.0 in 2014, then increased by 28.22% to $477178.0 in 2015, then plummeted by 77.33% to $108200.0 in 2016, then crashed by 94.55% to $5901.0 in 2017, then plummeted by 71.77% to $1666.0 in 2018.
  • Business Quant data shows Interest Expenses for LSTA at $1666.0 in Q2 2018, $3000.0 in Q1 2018, and $5901.0 in Q4 2017.